Greetings
Hwa Jong Kim
Head of the K-MELLODDY Project
Korea Pharmaceutical and
Bio-Pharma Manufacturers Association
AI has become an essential tool in drug development. Global tech giants like Google and NVIDIA are leveraging AI and partnering with major pharmaceutical companies worldwide to reshape the landscape of drug development and the digital bioindustry.
While Korea is also prioritizing bio and AI as next-generation core industries, the current approach may not be sufficient to keep pace with already leading advanced countries. We urgently need a strategy to lead in the next-generation bio-AI convergence industry.
The K-MELLODDY project aims to create an ecosystem where expensive and difficult-to-share bio data can be safely utilized collaboratively and applied effectively to drug development.
We hope that the successful execution of this project will serve as a turning point for Korea to become a leader in the AI-driven bioindustry.
We hope that the successful execution of this project will serve as a turning point for Korea to become a leader in the AI-driven bioindustry.
Thank you.
August. 2024